01808nam 2200469 450 991070304140332120221105123148.0(CKB)3450000000002396(NjHacI)993450000000002396(OCoLC)741122408(EXLCZ)99345000000000239620221105d2010 uy 0engur|||||||||||txtrdacontentcrdamediacrrdacarrierAssessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs /Ronald A. Booth [and seventeen others]Rockville, Maryland :Agency for Healthcare Research and Quality (US),[2010]©20101 online resource (288 pages) illustrationsEvidence Reports/Technology AssessmentsTitle from title screen (viewed on July 12, 2011)."EPC Director: David Moher, Ph.D.""Investigators: Ronald A. Booth, Ph.D. ... [et al.].""December 2010."Includes bibliographical references.Evidence report/technology assessment.Autoimmune diseasesAutoimmune diseases.616.978Booth Ronald A.Moher David1957-1194244Booth Ronald A1351417United States.Agency for Healthcare Research and Quality.University of Ottawa Evidence-based Practice Center.NjHacINjHaclBOOK9910703041403321Assessment of thiopurine methyltransferase activity in patients prescribed azathioprine or other thiopurine-based drugs3471071UNINA